Efficay of Physical Activity Program in PCOS Females With Fatty Pancrease and Thyroid Hypofunction
9. maj 2026 opdateret af: Ali Mohamed Ali ismail, Cairo University
females of polycystic ovary syndromes may complain fatty pancreaetic disorder and thyroid hypofunctions (subclinical hypothyroidism)
Studieoversigt
Status
Rekruttering
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
females of polycystic ovary syndromes may complain fatty pancreaetic disorder and thyroid hypofunctions (subclinical hypothyroidism) will be divided to groups (twenty female for the group).
groups will be treated with levothyroxine and metformin, but one of these groups will perform aerobic treadmill walking.
Undersøgelsestype
Interventionel
Tilmelding (Anslået)
40
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiekontakt
- Navn: Ali MA Ismail, lecturer
- Telefonnummer: 01005154209
- E-mail: ali.mohamed@pt.cu.edu.eg
Undersøgelse Kontakt Backup
- Navn: ali mohamed
- Telefonnummer: 01031321109
- E-mail: allooka2012@gmail.com
Studiesteder
-
-
-
Giza, Egypten
- Rekruttering
- Cairo Unoversity
-
Kontakt:
- Ali Ismail, lecturer
- Telefonnummer: 01005154209
- E-mail: allooka2012@gmail.com
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
Tager imod sunde frivillige
Ingen
Beskrivelse
Inclusion Criteria:
- PCOS
- fattty pancrease (non-alcoholic)
- subclinical hypothyroid (signifcant with thyroid stimauted horomone more than 10 mIU/L) and normal non-disordered free thyroxine horomones
Exclusion Criteria:
- cardiac disesase
- renal diseases
- respiratory disease
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: group number 1
twenty females of polycystic ovary syndromes may complain fatty pancreaetic disorder and thyroid hypofunctions (subclinical hypothyroidism)will be treated with daily dose of levothyroxine in addition to daily twotimes of 500-mg metformin, and these females will perform 50 minutes of aerobic treadmill walking hrice weekly for six month.
|
twenty females of polycystic ovary syndromes may complain fatty pancreaetic disorder and thyroid hypofunctions (subclinical hypothyroidism)will be treated with daily dose of levothyroxine in addition to daily twotimes of 500-mg metformin, and these females will perform 50 minutes of aerobic treadmill walking hrice weekly for six month.
|
|
Aktiv komparator: group number 2
twenty females of polycystic ovary syndromes may complain fatty pancreaetic disorder and thyroid hypofunctions (subclinical hypothyroidism)will be treated with daily dose of levothyroxine in addition to daily twotimes of 500-mg metformin for six month
|
twenty females of polycystic ovary syndromes may complain fatty pancreaetic disorder and thyroid hypofunctions (subclinical hypothyroidism)will be treated with daily dose of levothyroxine in addition to daily two times of 500-mg metformin for six month.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Dehydroepiandrosterone
Tidsramme: it will be measured after 6 months
|
it is a hormone involved in synthesis of sex hormones
|
it will be measured after 6 months
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
ratio of leutinzing hromone to hormone of follicels stimulatting hormones
Tidsramme: it will be measured after 6 months
|
this ration express level of sex hormone
|
it will be measured after 6 months
|
|
testesterone
Tidsramme: it will be measured after 6 months
|
it is a sex horomone
|
it will be measured after 6 months
|
|
body mass index
Tidsramme: it will be measured after 6 months
|
it will be assessed on empty stomach and bladder
|
it will be measured after 6 months
|
|
waist circumference
Tidsramme: it will be measured after 6 months
|
it will be assessed on umblical levels
|
it will be measured after 6 months
|
|
blood gluocose
Tidsramme: it will be measured after 6 months
|
it will be assessed in fasting status
|
it will be measured after 6 months
|
|
glycated hemoglubin
Tidsramme: it will be measured after 6 months
|
it is an indiactor for longterm satus of blood gloucose
|
it will be measured after 6 months
|
|
insulin
Tidsramme: it will be measured after 6 months
|
it will be assessed in plasma
|
it will be measured after 6 months
|
|
thyroid stimualtined horomone
Tidsramme: it will be measured after 6 months
|
it will be assessed in plasma
|
it will be measured after 6 months
|
|
triglyceridess
Tidsramme: it will be measured after 6 months
|
it will be assessed in plasma
|
it will be measured after 6 months
|
|
low densitiy liopporotein
Tidsramme: it will be measured after 6 months
|
it will be assessed in plasma
|
it will be measured after 6 months
|
|
cholesteroll
Tidsramme: it will be measured after 6 months
|
it will be assessed in plasma
|
it will be measured after 6 months
|
|
high densitiy lipoporteins
Tidsramme: it will be measured after 6 months
|
it will be assessed in plasma
|
it will be measured after 6 months
|
|
alanine transaminase
Tidsramme: it will be measured after 6 months
|
it will be assessed in plasma
|
it will be measured after 6 months
|
|
aspartatte transaminase
Tidsramme: it will be measured after 6 months
|
it will be assessed in plasma
|
it will be measured after 6 months
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Efterforskere
- Ledende efterforsker: Ali MA Ismail, lecturer, Cairo University
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
7. marts 2026
Primær færdiggørelse (Anslået)
30. december 2026
Studieafslutning (Anslået)
30. december 2026
Datoer for studieregistrering
Først indsendt
9. maj 2026
Først indsendt, der opfyldte QC-kriterier
9. maj 2026
Først opslået (Faktiske)
15. maj 2026
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
15. maj 2026
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
9. maj 2026
Sidst verificeret
1. maj 2026
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- IRB000-14233-74
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .